Focus Partners Wealth
CVS icon

Focus Partners Wealth’s CVS Health CVS Stock Holding History

Focus Partners Wealth’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.4M Sell
371,576
-133,523
-26% -$11.9M 0.04% 368
2026
Q1 		$36.3M Sell
505,099
-12,868
-2% -$991K 0.04% 357
2025
Q4 		$40.9M Buy
517,967
+219,979
+74% +$17.3M 0.05% 332
2025
Q3 		$22.5M Buy
297,988
+20,135
+7% +$1.38M 0.04% 381
2025
Q2 		$19.2M Sell
277,853
-47,183
-15% -$3.09M 0.04% 369
2025
Q1 		$22M Sell
325,036
-44,080
-12% -$2.64M 0.06% 305
2024
Q4 		$16.6M Sell
369,116
-87,998
-19% -$4.94M 0.04% 354
2024
Q3 		$28.7M Sell
457,114
-960,156
-68% -$56M 0.09% 218
2024
Q2 		$83.7M Buy
1,417,270
+821,990
+138% +$51.4M 0.28% 83
2024
Q1 		$47.5M Buy
595,280
+299,802
+101% +$22.9M 0.39% 59
2023
Q4 		$23.3M Buy
+295,478
New +$21M 0.31% 91

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Focus Partners Wealth's CVS Position: Q2 2026 in Review

Focus Partners Wealth reduced its CVS Health (CVS) stake by 26% in Q2 2026, selling an estimated $11.9M and leaving 371,576 shares worth $38.4M. The position accounts for 0.04% of the portfolio, ranked #368.

Focus Partners Wealth first reported a position in CVS in Q4 2023 and has held it in 11 quarters since. The position peaked at $83.7M in Q2 2024. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Focus Partners Wealth held 371,576 shares of CVS Health worth $38.4M as of Q2 2026.
  • Focus Partners Wealth sold 133,523 CVS Health shares in Q2 2026, an estimated $11.9M.
  • CVS Health made up 0.04% of Focus Partners Wealth's portfolio in Q2 2026, its #368 holding.
  • Focus Partners Wealth first reported a position in CVS Health in Q4 2023 and has held it in 11 quarters since.
  • Focus Partners Wealth's CVS Health position peaked at $83.7M in Q2 2024.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Focus Partners Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.